| Tissue invasion and metastasis: Molecular, biological and clinical perspectives WG Jiang, AJ Sanders, M Katoh, H Ungefroren, F Gieseler, M Prince, ... Seminars in cancer biology 35, S244-S275, 2015 | 568 | 2015 |
| Rechallenge for patients with RAS and BRAF wild-type metastatic colorectal cancer with acquired resistance to first-line cetuximab and irinotecan: a phase 2 single-arm clinical … C Cremolini, D Rossini, E Dell’Aquila, S Lonardi, E Conca, M Del Re, ... JAMA oncology 5 (3), 343-350, 2019 | 354 | 2019 |
| Designing a broad-spectrum integrative approach for cancer prevention and treatment KI Block, C Gyllenhaal, L Lowe, A Amedei, ARMR Amin, A Amin, ... Seminars in cancer biology 35, S276-S304, 2015 | 305 | 2015 |
| Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis FR Bertani, P Mozetic, M Fioramonti, M Iuliani, G Ribelli, F Pantano, ... Scientific reports 7 (1), 8965, 2017 | 231 | 2017 |
| Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples M Russano, A Napolitano, G Ribelli, M Iuliani, S Simonetti, F Citarella, ... Journal of Experimental & Clinical Cancer Research 39, 1-13, 2020 | 216 | 2020 |
| Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients D Santini, G Schiavon, B Vincenzi, L Gaeta, F Pantano, A Russo, ... PloS one 6 (4), e19234, 2011 | 207 | 2011 |
| Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases D Santini, G Perrone, I Roato, L Godio, F Pantano, D Grasso, A Russo, ... Journal of cellular physiology 226 (3), 780-784, 2011 | 178 | 2011 |
| Cetuximab: from bench to bedside B Vincenzi, A Zoccoli, F Pantano, O Venditti, S Galluzzo Current cancer drug targets 10 (1), 80, 2010 | 171 | 2010 |
| miRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis–associated genes M Croset, F Pantano, CWS Kan, E Bonnelye, F Descotes, ... Cancer research 78 (18), 5259-5273, 2018 | 165 | 2018 |
| Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and outcomes with nivolumab in pretreated non-small cell lung cancer (NSCLC): a large retrospective … A Russo, M Russano, T Franchina, MR Migliorino, G Aprile, G Mansueto, ... Advances in therapy 37, 1145-1155, 2020 | 134 | 2020 |
| Natural history of non-small-cell lung cancer with bone metastases D Santini, S Barni, S Intagliata, A Falcone, F Ferraù, D Galetta, L Moscetti, ... Scientific reports 5 (1), 1-9, 2015 | 114 | 2015 |
| The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients F Pantano, P Berti, FM Guida, G Perrone, B Vincenzi, MMC Amato, ... Journal of cellular and molecular medicine 17 (11), 1415-1421, 2013 | 102 | 2013 |
| New molecular targets in bone metastases D Santini, S Galluzzo, A Zoccoli, F Pantano, ME Fratto, B Vincenzi, ... Cancer treatment reviews 36, S6-S10, 2010 | 75 | 2010 |
| Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey N Silvestris, F Pantano, T Ibrahim, T Gamucci, F De Vita, T Di Palma, ... Plos one 8 (10), e74402, 2013 | 72 | 2013 |
| Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinoma M Santoni, F Pantano, C Amantini, M Nabissi, A Conti, L Burattini, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1845 (2), 221-231, 2014 | 70 | 2014 |
| Italian clinical practice guidelines on cholangiocarcinoma–Part II: treatment D Alvaro, C Hassan, V Cardinale, G Carpino, L Fabris, E Gringeri, ... Digestive and Liver Disease 52 (12), 1430-1442, 2020 | 69 | 2020 |
| Prognostic and predictive factors in pancreatic cancer E Dell’Aquila, CAM Fulgenzi, A Minelli, F Citarella, M Stellato, F Pantano, ... Oncotarget 11 (10), 924, 2020 | 67 | 2020 |
| Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions F Pantano, M Croset, K Driouch, N Bednarz-Knoll, M Iuliani, G Ribelli, ... Oncogene 40 (7), 1284-1299, 2021 | 64 | 2021 |
| Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer F Suriano, D Santini, G Perrone, M Amato, B Vincenzi, G Tonini, AO Muda, ... Journal of experimental & clinical cancer research 32, 1-7, 2013 | 63 | 2013 |
| Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells A Grimaldi, D Santini, S Zappavigna, A Lombardi, G Misso, M Boccellino, ... Cancer biology & therapy 16 (4), 567-579, 2015 | 59 | 2015 |
Michele CaragliaProfessore Ordinario di Biochimica, Università della Campania "L. Vanvitelli", Dipartimento diEmail verificata su unicampania.it
